Quick Takeaways:
- epiq Animal Health and Vetirus Animal Health entered into an exclusive US distribution and strategy agreement to expand access to Rebound High Performance PRP, a regenerative therapy for companion animals and equine patients.
- Rebound High Performance PRP is a university-validated, FDA-registered platelet-rich plasma solution designed to accelerate healing, reduce inflammation, and support tissue regeneration without requiring dedicated equipment.
- The companies will collaborate on distribution, supply chain support, education, and training initiatives across the US veterinary community, with the product available through animal health distribution channels.
Why It Matters?
This partnership is designed to scale Rebound High Performance PRP across the US veterinary market by combining epiq’s distribution reach with Vetirus’s product and regulatory credentials, removing a key barrier to adoption-access to equipment-free, validated PRP therapy.
The market implication is that veterinary regenerative medicine for musculoskeletal and soft-tissue conditions in companion animals and equines could see faster penetration, as clinics can now obtain a university-validated, FDA-registered PRP solution through standard animal health channels without capital investment in PRP processing equipment.
Source: Businesswire
